Status:
COMPLETED
Diagnostic of Iron Deficiency by Means of Non Invasive Measurement of Zink Protoporphyrin IX
Lead Sponsor:
Philipp Stein
Conditions:
Iron-deficiency
Eligibility:
All Genders
18+ years
Brief Summary
ZnPP is being build in the case of a functional iron deficiency. Zinc instead of iron is implemented into protoporphyrin IX. This ZincProtoporphyrin (ZnPP) can be detected non invasively. Non invasive...
Detailed Description
Zinc-protoporphyrin (ZnPP) will be measured by a fluorescence technique. Restricted wave light (407/425 nm) is used to detect ZnPP in the bloodstream non-invasively through the oral mucosa. The spectr...
Eligibility Criteria
Inclusion
- Patients seen preoperatively in the Anesthestic clinic
- Patients \> 18 years of age
- Understood and signed patient consent
Exclusion
- transfusion of blood products 8 weeks prior to screening
- Pregnancy
- Porphyria
Key Trial Info
Start Date :
July 27 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2018
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03231865
Start Date
July 27 2017
End Date
May 31 2018
Last Update
June 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091